Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02635360
Title Pembrolizumab and Chemoradiation Treatment for Advanced Cervical Cancer
Recruitment Active, not recruiting
Gender female
Phase Phase II
Variant Requirements No
Sponsors Linda R Duska
Indications

cervical cancer

Therapies

Cisplatin

Pembrolizumab

Age Groups: senior | adult
Covered Countries USA


No variant requirements are available.